Infections Bacterial Infections

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Bacterial Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Bacterial Infections Projects
--Asubio Pharma Co., Ltd.
--Asahi Kasei Corporation
--Hi-Tech Pharmacal Co Inc
--DAIICHI SANKYO COMPANY, LIMITED
--Meiji Seika Kaisha, Ltd.
--Kyoto Pharmaceutical Industries
--Paratek Pharmaceuticals, Inc
--Mylan, Inc.
--Ranbaxy Laboratories Ltd.
--Pfizer Inc
--Replidyne Inc
--RECORDATI SpA
--Roche Holdings Ltd
--Rib-X Pharmaceuticals, Inc.
--Star Laboratories
--Ltd.
--Schering-Plough Corp
--Teva Pharmaceutical Industries Ltd
--Taisho Pharmaceutical Co., Ltd.
--Yuhan Corporation
--TOYAMA CHEMICAL CO.,LTD.

--Top Companies in early stage Bacterial Infections Projects
--Affinium Pharmaceuticals, Inc.
--ADVENTRX Pharmaceuticals Inc
--Aphios Corporation
--Amura Holdings Ltd.
--Basilea Pharmaceutica AG
--Arpida Ltd.
--DAIICHI SANKYO COMPANY, LIMITED
--Cangene Corporation
--Forest Laboratories Inc
--Dainippon Sumitomo Pharma Co., Ltd.
--Grupo Ferrer
--GlaxoSmithKline plc
--Intercell AG
--Inimex Pharmaceuticals Inc.
--Pfizer Inc
--Paratek Pharmaceuticals, Inc
--Trius Therapeutics
--erly Rx3 Pharmaceuticals, Inc.)
--Prolysis Limited
--Wyeth
--Vertex Pharmaceuticals Inc

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View